{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T07:19:02Z","timestamp":1777792742850,"version":"3.51.4"},"reference-count":97,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Zhejiang Province Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022963","name":"Key Research and Development Program of Zhejiang Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008990","name":"Zhejiang Province Science and Technology Department","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008990","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.pharmthera.2026.109001","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T16:22:47Z","timestamp":1771604567000},"page":"109001","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["P2Y14 receptor in the nervous system: Pharmacology, mechanisms, and therapeutic potential"],"prefix":"10.1016","volume":"282","author":[{"given":"Jiu","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxia","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingjie","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feihong","family":"Gan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Ciruela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiyong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyi","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.pharmthera.2026.109001_bb0005","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0165-6147(02)00038-X","article-title":"Characterization of the UDP-glucose receptor (re-named here the P2Y14 receptor) adds diversity to the P2Y receptor family","volume":"24","author":"Abbracchio","year":"2003","journal-title":"Trends in Pharmacological Sciences"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109001_bb0010","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1124\/pr.58.3.3","article-title":"International Union of Pharmacology LVIII: Update on the P2Y G protein-coupled nucleotide receptors: From molecular mechanisms and pathophysiology to therapy","volume":"58","author":"Abbracchio","year":"2006","journal-title":"Pharmacological Reviews"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109001_bb0015","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s11302-007-9069-8","article-title":"Mapping P2X and P2Y receptor proteins in striatum and substantia nigra: An immunohistological study","volume":"3","author":"Amadio","year":"2007","journal-title":"Purinergic Signal"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109001_bb0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0121419","article-title":"Renal intercalated cells sense and mediate inflammation via the P2Y14 receptor","volume":"10","author":"Azroyan","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109001_bb0025","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1124\/mol.113.085654","article-title":"A selective high-affinity antagonist of the P2Y14 receptor inhibits UDP-glucose-stimulated chemotaxis of human neutrophils","volume":"84","author":"Barrett","year":"2013","journal-title":"Molecular Pharmacology"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.109001_bb0030","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.1172\/JCI134791","article-title":"Proinflammatory P2Y14 receptor inhibition protects against ischemic acute kidney injury in mice","volume":"130","author":"Battistone","year":"2020","journal-title":"The Journal of Clinical Investigation"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109001_bb0035","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.brainresrev.2004.12.004","article-title":"Pathophysiological roles of extracellular nucleotides in glial cells: Differential expression of purinergic receptors in resting and activated microglia","volume":"48","author":"Bianco","year":"2005","journal-title":"Brain Research. Brain Research Reviews"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109001_bb0040","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/0306-3623(85)90001-1","article-title":"Is there a basis for distinguishing two types of P2-purinoceptor?","volume":"16","author":"Burnstock","year":"1985","journal-title":"General Pharmacology"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109001_bb0045","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s11302-005-6211-3","article-title":"Cerebellar astrocytes co-express several ADP receptors. Presence of functional P2Y(13)-like receptors","volume":"1","author":"Carrasquero","year":"2005","journal-title":"Purinergic Signal"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109001_bb0050","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1124\/mol.109.058578","article-title":"Quantification of Gi-mediated inhibition of adenylyl cyclase activity reveals that UDP is a potent agonist of the human P2Y14 receptor","volume":"76","author":"Carter","year":"2009","journal-title":"Molecular Pharmacology"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109001_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26062379","article-title":"Temporal mRNA expression of purinergic P2 receptors in the brain following cerebral ischemia and reperfusion: Similarities and distinct variations between rats and mice","volume":"26","author":"Challa","year":"2025","journal-title":"International Journal of Molecular Sciences"},{"issue":"15","key":"10.1016\/j.pharmthera.2026.109001_bb0060","doi-asserted-by":"crossref","first-page":"10767","DOI":"10.1074\/jbc.275.15.10767","article-title":"A G protein-coupled receptor for UDP-glucose","volume":"275","author":"Chambers","year":"2000","journal-title":"The Journal of Biological Chemistry"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2026.109001_bb0065","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0006-8993(97)00438-1","article-title":"The isolation and characterization of a novel G protein-coupled receptor regulated by immunologic challenge","volume":"764","author":"Charlton","year":"1997","journal-title":"Brain Research"},{"issue":"22","key":"10.1016\/j.pharmthera.2026.109001_bb0070","doi-asserted-by":"crossref","first-page":"5393","DOI":"10.1021\/jm049914c","article-title":"Architecture of P2Y nucleotide receptors: Structural comparison based on sequence analysis, mutagenesis, and homology modeling","volume":"47","author":"Costanzi","year":"2004","journal-title":"Journal of Medicinal Chemistry"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109001_bb0075","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11060-017-2700-9","article-title":"P2Y14 receptor activation decreases interleukin-6 production and glioma GL261 cell proliferation in microglial transwell cultures","volume":"137","author":"Curet","year":"2018","journal-title":"Journal of Neuro-Oncology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109001_bb0080","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1021\/jm901432g","article-title":"Human P2Y(14) receptor agonists: Truncation of the hexose moiety of uridine-5\u2032-diphosphoglucose and its replacement with alkyl and aryl groups","volume":"53","author":"Das","year":"2010","journal-title":"Journal of Medicinal Chemistry"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109001_bb0085","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1007\/s00424-006-0069-2","article-title":"P2 receptors: Intracellular signaling","volume":"452","author":"Erb","year":"2006","journal-title":"Pfl\u00fcgers Archiv"},{"key":"10.1016\/j.pharmthera.2026.109001_bb0095","article-title":"Targeting P2Y14R alleviates platelet-induced NET formation and venous thrombosis through PKA\/AKAP13\/RhoA axis","author":"Fang","year":"2025","journal-title":"European Heart Journal"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109001_bb0100","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1177\/17474930241308142","article-title":"World stroke organization: Global stroke fact sheet 2025","volume":"20","author":"Feigin","year":"2025","journal-title":"International Journal of Stroke"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109001_bb0105","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1006\/geno.2001.6662","article-title":"Cloning, pharmacology, and tissue distribution of G-protein-coupled receptor GPR105 (KIAA0001) rodent orthologs","volume":"78","author":"Freeman","year":"2001","journal-title":"Genomics"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109001_bb0110","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1124\/jpet.109.150730","article-title":"Gi-dependent cell signaling responses of the human P2Y14 receptor in model cell systems","volume":"330","author":"Fricks","year":"2009","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109001_bb0115","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/glia.10248","article-title":"Nucleotide-mediated calcium signaling in rat cortical astrocytes: Role of P2X and P2Y receptors","volume":"43","author":"Fumagalli","year":"2003","journal-title":"Glia"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109001_bb0120","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.bcp.2009.10.024","article-title":"UDP-glucose acting at P2Y14 receptors is a mediator of mast cell degranulation","volume":"79","author":"Gao","year":"2010","journal-title":"Biochemical Pharmacology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109001_bb0125","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41421-025-00799-9","article-title":"Structural insights into ligand recognition and activation of human purinergic receptor P2Y14","volume":"11","author":"Gu","year":"2025","journal-title":"Cell Discovery"},{"key":"10.1016\/j.pharmthera.2026.109001_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.107908","article-title":"Exosome-mediated microglia-astrocyte interactions drive neuroinflammation in Parkinson's disease with Peli1 as a potential therapeutic target","volume":"219","author":"Guo","year":"2025","journal-title":"Pharmacological Research"},{"key":"10.1016\/j.pharmthera.2026.109001_bb0135","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jare.2024.03.027","article-title":"Comprehensive insights into potential roles of purinergic P2 receptors on diseases: Signaling pathways involved and potential therapeutics","volume":"69","author":"Guo","year":"2025","journal-title":"Journal of Advanced Research"},{"issue":"17","key":"10.1016\/j.pharmthera.2026.109001_bb0140","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1016\/j.febslet.2014.05.044","article-title":"Characterization of the contractile P2Y14 receptor in mouse coronary and cerebral arteries","volume":"588","author":"Haanes","year":"2014","journal-title":"FEBS Letters"},{"key":"10.1016\/j.pharmthera.2026.109001_bb0145","doi-asserted-by":"crossref","first-page":"7215","DOI":"10.2147\/DDDT.S497291","article-title":"Design, synthesis and anti-inflammation evaluation of N-acyl tryptophan derivatives as promising P2Y(14)R antagonists against lipopolysaccharide-induced acute lung injury","volume":"19","author":"Han","year":"2025","journal-title":"Drug Design, Development and Therapy"},{"issue":"10446","key":"10.1016\/j.pharmthera.2026.109001_bb0150","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1016\/S0140-6736(24)00642-1","article-title":"Stroke","volume":"403","author":"Hilkens","year":"2024","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109001_bb0155","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1136\/gut.52.1.144","article-title":"Mitogen activated protein (MAP) kinase signal transduction pathways and novel anti-inflammatory targets","volume":"52","author":"Hommes","year":"2003","journal-title":"Gut"},{"issue":"13","key":"10.1016\/j.pharmthera.2026.109001_bb0160","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1111\/bph.70024","article-title":"P2Y(14) receptor activation of platelets induces ca(2+) mobilization and rho-GTPase-dependent motility that requires an interaction with P2Y(1) receptors","volume":"182","author":"Hossain","year":"2025","journal-title":"British Journal of Pharmacology"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.109001_bb0165","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1002\/glia.22541","article-title":"Communication between neuronal somata and satellite glial cells in sensory ganglia","volume":"61","author":"Huang","year":"2013","journal-title":"Glia"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109001_bb0170","doi-asserted-by":"crossref","DOI":"10.3390\/cells9051108","article-title":"Regulation of microglial functions by purinergic mechanisms in the healthy and diseased CNS","volume":"9","author":"Illes","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.pharmthera.2026.109001_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106631","article-title":"Role of monomeric amyloid-\u03b2 in cognitive performance in Alzheimer\u2019s disease: Insights from clinical trials with secretase inhibitors and monoclonal antibodies","volume":"187","author":"Imbimbo","year":"2023","journal-title":"Pharmacological Research"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.109001_bb0180","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.146577","article-title":"Adipocyte P2Y14 receptors play a key role in regulating whole-body glucose and lipid homeostasis","volume":"6","author":"Jain","year":"2021","journal-title":"JCI Insight"},{"issue":"6312","key":"10.1016\/j.pharmthera.2026.109001_bb0185","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1126\/science.aaf8924","article-title":"Pain regulation by non-neuronal cells and inflammation","volume":"354","author":"Ji","year":"2016","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109001_bb0190","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/ALN.0000000000002130","article-title":"Neuroinflammation and central sensitization in chronic and widespread pain","volume":"129","author":"Ji","year":"2018","journal-title":"Anesthesiology"},{"issue":"17","key":"10.1016\/j.pharmthera.2026.109001_bb0195","doi-asserted-by":"crossref","first-page":"9563","DOI":"10.1021\/acs.jmedchem.0c00745","article-title":"Exploration of alternative scaffolds for P2Y(14) receptor antagonists containing a Biaryl Core","volume":"63","author":"Jung","year":"2020","journal-title":"Journal of Medicinal Chemistry"},{"issue":"13","key":"10.1016\/j.pharmthera.2026.109001_bb0200","doi-asserted-by":"crossref","first-page":"6149","DOI":"10.1021\/acs.jmedchem.6b00044","article-title":"Structure-based design of 3-(4-aryl-1H-1,2,3-triazol-1-yl)-biphenyl derivatives as P2Y14 receptor antagonists","volume":"59","author":"Junker","year":"2016","journal-title":"Journal of Medicinal Chemistry"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109001_bb0205","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1161\/STROKEAHA.123.044422","article-title":"UDP-glucose\/P2Y14 receptor signaling exacerbates neuronal apoptosis after subarachnoid hemorrhage in rats","volume":"55","author":"Kanamaru","year":"2024","journal-title":"Stroke"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.109001_bb0210","doi-asserted-by":"crossref","DOI":"10.1172\/JCI140709","article-title":"UDP-glucose and P2Y14 receptor amplify allergen-induced airway eosinophilia","volume":"131","author":"Karcz","year":"2021","journal-title":"The Journal of Clinical Investigation"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109001_bb0215","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s10571-012-9869-4","article-title":"Secretion of matrix metalloproteinase-9 from astrocytes by inhibition of tonic P2Y14-receptor-mediated signal(s)","volume":"33","author":"Kinoshita","year":"2013","journal-title":"Cellular and Molecular Neurobiology"},{"issue":"12","key":"10.1016\/j.pharmthera.2026.109001_bb0220","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1021\/cb500614p","article-title":"Exploring a 2-naphthoic acid template for the structure-based design of P2Y14 receptor antagonist molecular probes","volume":"9","author":"Kiselev","year":"2014","journal-title":"ACS Chemical Biology"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109001_bb0225","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1021\/jm061222w","article-title":"Structure-activity relationship of uridine 5\u2032-diphosphoglucose analogues as agonists of the human P2Y14 receptor","volume":"50","author":"Ko","year":"2007","journal-title":"Journal of Medicinal Chemistry"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109001_bb0230","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/cne.21066","article-title":"Neurons and glial cells differentially express P2Y receptor mRNAs in the rat dorsal root ganglion and spinal cord","volume":"498","author":"Kobayashi","year":"2006","journal-title":"The Journal of Comparative Neurology"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.109001_bb0235","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1002\/glia.22373","article-title":"Multiple P2Y subtypes in spinal microglia are involved in neuropathic pain after peripheral nerve injury","volume":"60","author":"Kobayashi","year":"2012","journal-title":"Glia"},{"issue":"1\u20133","key":"10.1016\/j.pharmthera.2026.109001_bb0240","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejphar.2008.06.092","article-title":"The P2Y14 receptor activity in glioma C6 cells","volume":"594","author":"Krzemi\u0144ski","year":"2008","journal-title":"European Journal of Pharmacology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109001_bb0245","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1124\/mol.115.098756","article-title":"UDP-sugars as extracellular signaling molecules: Cellular and physiologic consequences of P2Y14 receptor activation","volume":"88","author":"Lazarowski","year":"2015","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.pharmthera.2026.109001_bb9098","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jep.2016.03.025","article-title":"Geniposide attenuates inflammatory response by suppressing P2Y14 receptor and downstream ERK1\/2 signaling pathway in oxygen and glucose deprivation-induced brain microvascular endothelial cells","volume":"185","author":"Li","year":"2016","journal-title":"J Ethnopharmacol"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109001_bb0250","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/s41419-020-2609-7","article-title":"P2Y(14) receptor has a critical role in acute gouty arthritis by regulating pyroptosis of macrophages","volume":"11","author":"Li","year":"2020","journal-title":"Cell Death & Disease"},{"key":"10.1016\/j.pharmthera.2026.109001_bib486","doi-asserted-by":"crossref","first-page":"121805","DOI":"10.1016\/j.lfs.2023.121805","article-title":"Upregulation of P2Y14 receptor in neutrophils promotes inflammation after myocardial ischemia\/reperfusion injury","volume":"326","author":"Li","year":"2023","journal-title":"Life Science"},{"key":"10.1016\/j.pharmthera.2026.109001_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154851","article-title":"Structure-based virtual screening for discovery of paederosidic acid from Paederia scandens as novel P2Y(14)R antagonist","volume":"115","author":"Li","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.pharmthera.2026.109001_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175211","article-title":"P2Y(14) receptor in trigeminal ganglion contributes to neuropathic pain in mice","volume":"931","author":"Lin","year":"2022","journal-title":"European Journal of Pharmacology"},{"issue":"11","key":"10.1016\/j.pharmthera.2026.109001_bb0265","doi-asserted-by":"crossref","first-page":"21199","DOI":"10.1002\/jcp.28726","article-title":"P2Y(14) receptor is functionally expressed in satellite glial cells and mediates interleukin-1\u03b2 and chemokine CCL2 secretion","volume":"234","author":"Lin","year":"2019","journal-title":"Journal of Cellular Physiology"},{"key":"10.1016\/j.pharmthera.2026.109001_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2019.104567","article-title":"The P2Y(14) receptor in the trigeminal ganglion contributes to the maintenance of inflammatory pain","volume":"131","author":"Lin","year":"2019","journal-title":"Neurochemistry International"},{"key":"10.1016\/j.pharmthera.2026.109001_bb0275","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.lfs.2016.03.037","article-title":"Decoding g\u03b1q signaling","volume":"152","author":"Litosch","year":"2016","journal-title":"Life Sciences"},{"key":"10.1016\/j.pharmthera.2026.109001_bb0280","article-title":"GPR105-targeted therapy promotes gout resolution as a switch between NETosis and apoptosis of neutrophils","volume":"13","author":"Liu","year":"2022","journal-title":"Frontiers in Immunology"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109001_bb0290","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/intimm\/dxad050","article-title":"The UDP-glucose\/P2Y14 receptor axis promotes eosinophil-dependent large intestinal inflammation","volume":"36","author":"Liu","year":"2024","journal-title":"International Immunology"},{"issue":"12","key":"10.1016\/j.pharmthera.2026.109001_bb0295","doi-asserted-by":"crossref","first-page":"10233","DOI":"10.1021\/acs.jmedchem.4c00555","article-title":"Discovery of N-substituted Acetamide derivatives as promising P2Y(14)R antagonists using molecular hybridization based on crystallographic overlay","volume":"67","author":"Liu","year":"2024","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2026.109001_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113313","article-title":"Design, synthesis and evaluation of 3-amide-5-aryl benzoic acid derivatives as novel P2Y(14)R antagonists with potential high efficiency against acute gouty arthritis","volume":"216","author":"Lu","year":"2021","journal-title":"European Journal of Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2026.109001_bb0305","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ejmech.2019.04.068","article-title":"Recent progress on the discovery of P2Y(14) receptor antagonists","volume":"175","author":"Lu","year":"2019","journal-title":"European Journal of Medicinal Chemistry"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109001_bb0310","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1038\/s41467-020-15636-8","article-title":"Glycogen metabolism regulates macrophage-mediated acute inflammatory responses","volume":"11","author":"Ma","year":"2020","journal-title":"Nature Communications"},{"key":"10.1016\/j.pharmthera.2026.109001_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117588","article-title":"Discovery of a series of novel 3-sulfonamido benzoic acid derivatives as promising P2Y(14)R antagonists for acute lung injury","volume":"290","author":"Ma","year":"2025","journal-title":"European Journal of Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2026.109001_bb0320","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1744-8069-6-21","article-title":"Gi- and Gq-coupled ADP (P2Y) receptors act in opposition to modulate nociceptive signaling and inflammatory pain behavior","volume":"6","author":"Malin","year":"2010","journal-title":"Molecular Pain"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109001_bb0325","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1021\/acs.jmedchem.4c01539","article-title":"Design, synthesis and anti-inflammatory evaluation of 3-substituted 5-Amidobenzoate derivatives as novel P2Y(14) receptor antagonists via structure-guided molecular hybridization","volume":"68","author":"Mao","year":"2025","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2026.109001_bb0330","doi-asserted-by":"crossref","unstructured":"Mederacke, I., Filliol, A., Affo, S., Nair, A., Hernandez, C., Sun, Q., Hamberger, F., Brundu, F., Chen, Y., Ravichandra, A., Huebener, P., Anke, H., Shi, H., Mart\u00ednez Garc\u00eda de la Torre, R. A., Smith, J. R., Henderson, N. C., Vondran, F. W. R., Rothlin, C. V., Baehre, H.,\u2026Schwabe, R. F. (2022). The purinergic P2Y14 receptor links hepatocyte death to hepatic stellate cell activation and fibrogenesis in the liver. Science Translational Medicine, 14(639), eabe5795. doi:https:\/\/doi.org\/10.1126\/scitranslmed.abe5795.","DOI":"10.1126\/scitranslmed.abe5795"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109001_bb0335","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1124\/jpet.109.154724","article-title":"Matrix metalloprotease-9 inhibition improves amyloid beta-mediated cognitive impairment and neurotoxicity in mice","volume":"331","author":"Mizoguchi","year":"2009","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2026.109001_bb0340","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0169-328X(03)00330-9","article-title":"GPR105, a novel Gi\/o-coupled UDP-glucose receptor expressed on brain glia and peripheral immune cells, is regulated by immunologic challenge: Possible role in neuroimmune function","volume":"118","author":"Moore","year":"2003","journal-title":"Brain Research. Molecular Brain Research"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109001_bb0345","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1021\/acsmedchemlett.0c00115","article-title":"P2Y(14) receptor antagonists reverse chronic neuropathic pain in a mouse model","volume":"11","author":"Mufti","year":"2020","journal-title":"ACS Medicinal Chemistry Letters"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109001_bb0350","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S0008-6363(02)00332-2","article-title":"Acetylcholine leads to free radical production dependent on K(ATP) channels, G(i) proteins, phosphatidylinositol 3-kinase and tyrosine kinase","volume":"55","author":"Oldenburg","year":"2002","journal-title":"Cardiovascular Research"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109001_bb0355","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s11302-024-10003-4","article-title":"Machine learning-aided search for ligands of P2Y(6) and other P2Y receptors","volume":"20","author":"Puhl","year":"2024","journal-title":"Purinergic Signal"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109001_bb0360","doi-asserted-by":"crossref","first-page":"9057","DOI":"10.1021\/acs.jmedchem.5c00249","article-title":"Drug-like antagonists of P2Y receptor subtypes: An update","volume":"68","author":"Puthanveedu","year":"2025","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2026.109001_bb0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.107884","article-title":"Beyond the surface: P2Y receptor downstream pathways, TLR crosstalk and therapeutic implications for infection and autoimmunity","volume":"219","author":"Rueschpler","year":"2025","journal-title":"Pharmacological Research"},{"key":"10.1016\/j.pharmthera.2026.109001_bb0370","first-page":"373","article-title":"Role of cytokines in inflammatory process in Parkinson's disease","volume":"Suppl(70)","author":"Sawada","year":"2006","journal-title":"Journal of Neural Transmission"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109001_bb0375","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/sj.bjp.0706322","article-title":"Functional expression of the P2Y14 receptor in murine T-lymphocytes","volume":"146","author":"Scrivens","year":"2005","journal-title":"British Journal of Pharmacology"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109001_bb0380","doi-asserted-by":"crossref","first-page":"C490","DOI":"10.1152\/ajpcell.00138.2012","article-title":"The UDP-sugar-sensing P2Y(14) receptor promotes rho-mediated signaling and chemotaxis in human neutrophils","volume":"303","author":"Sesma","year":"2012","journal-title":"American Journal of Physiology. Cell Physiology"},{"issue":"14","key":"10.1016\/j.pharmthera.2026.109001_bb0385","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1007\/s00018-008-8006-5","article-title":"G protein \u03b2\u03b3 subunits: Central mediators of G protein-coupled receptor signaling","volume":"65","author":"Smrcka","year":"2008","journal-title":"Cellular and Molecular Life Sciences"},{"key":"10.1016\/j.pharmthera.2026.109001_bb0390","article-title":"Naringin relieves diabetic cardiac autonomic neuropathy mediated by P2Y(14) receptor in superior cervical ganglion","volume":"13","author":"Tang","year":"2022","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.pharmthera.2026.109001_bb0395","article-title":"Computational discovery and repurposing of chloramphenicol succinate as a potent P2Y(14) receptor antagonist for inflammatory bowel disease therapy","author":"Tian","year":"2025","journal-title":"Journal of Advanced Research"},{"issue":"19","key":"10.1016\/j.pharmthera.2026.109001_bb0400","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231911025","article-title":"Molecular mechanisms underlying ca(2+)\/calmodulin-dependent protein kinase kinase signal transduction","volume":"23","author":"Tokumitsu","year":"2022","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2026.109001_bb0405","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1744-8069-5-70","article-title":"Differential regulation of immune responses and macrophage\/neuron interactions in the dorsal root ganglion in young and adult rats following nerve injury","volume":"5","author":"Vega-Avelaira","year":"2009","journal-title":"Molecular Pain"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109001_bb0410","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1080\/13543776.2024.2369634","article-title":"Recent advances in the development of P2Y(14)R inhibitors: A patent and literature review (2018-present)","volume":"34","author":"Wang","year":"2024","journal-title":"Expert Opinion on Therapeutic Patents"},{"key":"10.1016\/j.pharmthera.2026.109001_bb0415","article-title":"UDPG\/P2Y(14)-STAT1 axis mediates LPS-induced reactive astrogliosis","author":"Wang","year":"2025","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2026.109001_bb0420","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jare.2020.02.007","article-title":"Discovery of novel and potent P2Y(14)R antagonists via structure-based virtual screening for the treatment of acute gouty arthritis","volume":"23","author":"Wang","year":"2020","journal-title":"Journal of Advanced Research"},{"issue":"14","key":"10.1016\/j.pharmthera.2026.109001_bb0425","doi-asserted-by":"crossref","first-page":"11989","DOI":"10.1021\/acs.jmedchem.4c00699","article-title":"Discovery of a series of 4-amide-thiophene-2-carboxyl derivatives as highly potent P2Y(14) receptor antagonists for inflammatory bowel disease treatment","volume":"67","author":"Wang","year":"2024","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2026.109001_bb0430","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117451","article-title":"Discovery of a potent and in vivo anti-inflammatory efficacious, P2Y(14)R antagonist with a novel benzisoxazoles scaffold by DNA-encoded chemical library technology","volume":"289","author":"Wei","year":"2025","journal-title":"European Journal of Medicinal Chemistry"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.109001_bb0435","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1021\/acsptsci.4c00489","article-title":"Chimeras derived from a P2Y(14) receptor antagonist and UDP-sugar agonists for potential treatment of inflammation","volume":"7","author":"Wen","year":"2024","journal-title":"ACS Pharmacology & Translational Science"},{"issue":"13","key":"10.1016\/j.pharmthera.2026.109001_bb0440","doi-asserted-by":"crossref","first-page":"9076","DOI":"10.1021\/acs.jmedchem.3c00664","article-title":"Alicyclic ring size variation of 4-Phenyl-2-naphthoic acid derivatives as P2Y(14) receptor antagonists","volume":"66","author":"Wen","year":"2023","journal-title":"Journal of Medicinal Chemistry"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.109001_bb0445","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nrd1852","article-title":"Chemokines: Integrators of pain and inflammation","volume":"4","author":"White","year":"2005","journal-title":"Nature Reviews. Drug Discovery"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109001_bb0450","doi-asserted-by":"crossref","first-page":"5504","DOI":"10.1007\/s12035-022-02925-0","article-title":"LncRNA-UC.25+shRNA alleviates P2Y(14) receptor-mediated diabetic neuropathic pain via STAT1","volume":"59","author":"Wu","year":"2022","journal-title":"Molecular Neurobiology"},{"key":"10.1016\/j.pharmthera.2026.109001_bb0455","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2024.118005","article-title":"Reyanning mixture inhibits M1 macrophage polarization through the glycogen synthesis pathway to improve lipopolysaccharide-induced acute lung injury","volume":"328","author":"Yan","year":"2024","journal-title":"Journal of Ethnopharmacology"},{"key":"10.1016\/j.pharmthera.2026.109001_bb0460","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2023.109655","article-title":"UDP-glucose sensing P2Y(14)R: A novel target for inflammation","volume":"238","author":"Zhang","year":"2023","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2026.109001_bb0465","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111564","article-title":"Design, synthesis and anti-inflammatory evaluation of 3-amide benzoic acid derivatives as novel P2Y(14) receptor antagonists","volume":"181","author":"Zhang","year":"2019","journal-title":"European Journal of Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2026.109001_bb0470","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.85449","article-title":"Identification of a carbohydrate recognition motif of purinergic receptors","volume":"12","author":"Zhao","year":"2023","journal-title":"Elife"},{"key":"10.1016\/j.pharmthera.2026.109001_bb0475","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109507","article-title":"HQL6 serves as a novel P2Y(14) receptor antagonist to ameliorate acute gouty arthritis through inhibiting macrophage pyroptosis","volume":"114","author":"Zhou","year":"2023","journal-title":"International Immunopharmacology"},{"key":"10.1016\/j.pharmthera.2026.109001_bb0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113933","article-title":"Discovery and computational studies of 2-phenyl-benzoxazole acetamide derivatives as promising P2Y(14)R antagonists with anti-gout potential","volume":"227","author":"Zhou","year":"2022","journal-title":"European Journal of Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2026.109001_bb0485","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.brainresbull.2021.09.013","article-title":"Microglial P2Y14 receptor contributes to central sensitization following repeated inflammatory dural stimulation","volume":"177","author":"Zhu","year":"2021","journal-title":"Brain Research Bulletin"}],"container-title":["Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725826000288?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725826000288?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T20:07:54Z","timestamp":1777493274000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725826000288"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":97,"alternative-id":["S0163725826000288"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2026.109001","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"P2Y14 receptor in the nervous system: Pharmacology, mechanisms, and therapeutic potential","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2026.109001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109001"}}